In our study poor 90d outcomes were associated with enrichment of Thrombin pathways at 5 h and 24 h, Thrombopoietin Signaling at 5 h and the Intrinsic Prothrombin Activation Pathway at 24 h after stroke. The gene discussed is THPO; the disease is stroke disorder.